Status:
UNKNOWN
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients
Lead Sponsor:
The Catholic University of Korea
Conditions:
Liver Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Long-term immunosuppression carries potential adverse effects such as risk of infection, malignancy, renal insufficiency, diabetes and hypertension. In clinical liver transplantation, some liver trans...
Detailed Description
Among long term stable liver transplant recipients, we will select some proportion of patients who have the high potential for obtaining operational tolerance using biomarkers. Then, we will graduall...
Eligibility Criteria
Inclusion
- long term stable liver transplant recipients
Exclusion
- liver transplant due to autoimmune disease
- liver transplant due to hepatitis C virus (HCV)
- history of graft rejection
- history of biliary infection or stricture
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01198314
Start Date
July 1 2010
End Date
March 1 2013
Last Update
September 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul St. Mary's Hospital
Seoul, South Korea, 137-040